IPO registrations (S-1, F-1) · Registrants
Sol-Gel Technologies Ltd.
- SEC CIK
- 1684693 · filings on EDGAR ↗
- Registration
- Form F-1, first filed 2017-08-29, last 2023-03-10; 2 initial registrations, 5 amendments
- Outcome
- Final prospectus filed 2018-02-02; declared effective 2018-01-31
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- L3
- Business address
- 7 GOLDA MEIR ST., WEIZMANN SCIENCE PARK, Ness Ziona 7403648
- Ticker
- SLGL (Nasdaq)
- EDGAR entity type
- other
- Insiders and CEO pay
- Sol-Gel Technologies Ltd. on the corporate pages
Offering terms
- Proposed price range
- $11.00–$13.00 per share (F-1/A filed 2018-01-30)
- Final price
- $12.00 per share, within the range (424B4 filed 2018-02-02, an initial public offering)
- Shares sold
- 6,250,000
- Gross proceeds
- $75,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol SLGL
- Lead underwriters
- Jefferies; BMO Capital Markets
- Syndicate
- JMP Securities; Raymond James
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- SEC filer: Sol-Gel Technologies Ltd. EXACT (CIK (EXACT))
Filings 13
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2017-08-29 | F-1 | F-1 (foreign registration) | Sol-Gel Technologies Ltd. | 0001571049-17-007701 ↗ |
| 2017-09-06 | F-1/A | F-1/A (amendment) | Sol-Gel Technologies Ltd. | 0001571049-17-007780 ↗ |
| 2017-09-20 | F-1/A | F-1/A (amendment) | Sol-Gel Technologies Ltd. | 0001571049-17-007981 ↗ |
| 2017-12-29 | F-1/A | F-1/A (amendment) | Sol-Gel Technologies Ltd. | 0001571049-17-008774 ↗ |
| 2018-01-23 | F-1/A | F-1/A (amendment) | Sol-Gel Technologies Ltd. | 0001144204-18-003151 ↗ |
| 2018-01-30 | F-1/A | F-1/A (amendment) | Sol-Gel Technologies Ltd. | 0001144204-18-004431 ↗ |
| 2018-01-31 | EFFECT | EFFECT (declared effective) | Sol-Gel Technologies Ltd. | 9999999995-18-000281 ↗ |
| 2018-02-02 | 424B4 | 424B4 (final prospectus) | Sol-Gel Technologies Ltd. | 0001144204-18-005301 ↗ |
| 2019-04-12 | EFFECT | EFFECT (declared effective) | Sol-Gel Technologies Ltd. | 9999999995-19-000694 ↗ |
| 2022-04-13 | EFFECT | EFFECT (declared effective) | Sol-Gel Technologies Ltd. | 9999999995-22-000967 ↗ |
| 2023-03-10 | F-1 | F-1 (foreign registration) | Sol-Gel Technologies Ltd. | 0001178913-23-000920 ↗ |
| 2023-05-05 | EFFECT | EFFECT (declared effective) | Sol-Gel Technologies Ltd. | 9999999995-23-001316 ↗ |
| 2024-04-01 | EFFECT | EFFECT (declared effective) | Sol-Gel Technologies Ltd. | 9999999995-24-000805 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-01-30 | F-1/A | registration statement | $11.00–$13.00 | 5,000,000 | - | Nasdaq SLGL | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2018-02-02 | 424B4 | final prospectus | $12.00 | 6,250,000 | $75,000,000 | Nasdaq SLGL | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Opaleye Management Inc. | TenPercentOwner | 26 | 2025–2026 | ||
| Arkin Itai Gidon | Director | 1 | 2026 | ||
| Arkin Moshe | Director,Officer,TenPercentOwner | Chairman of Board and CEO | 1 | 2026 | |
| Ben-Or Eyal | Officer | Chief Financial Officer | 1 | 2026 | |
| Glezin Michael | Officer | Chief Business Officer | 1 | 2026 | |
| Gottfried Ran | Director | 1 | 2026 | ||
| Kochan Sharon | Director | 1 | 2026 | ||
| Lerman Hanna | Director | 1 | 2026 | ||
| Levy-Hacham Ofra | Officer | VP Clinical, Reg & Quality | 1 | 2026 | |
| Toledano Ofer | Officer | VP Research & Dev. | 1 | 2026 | |
| Yanai Yuval | Director | 1 | 2026 | ||
| Yosef Itzik | Officer | Chief Operating Officer | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | Sol-Gel Technologies Ltd. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations:
- MorphoSys AG 2M
- Affimed N.V. 2M
- InflaRx N.V. 2M
- Biofrontera AG 2M
- CURAXIS PHARMACEUTICAL Corp 2Q
- ONCOGENEX TECHNOLOGIES INC A1
- Aspreva Pharmaceuticals CORP A1
- Lexaria Bioscience Corp. A1
- Zymeworks BC Inc. A1
- BetterLife Pharma Inc. A1
Interests: Pharmaceutical Preparations · Health